Results 51 to 60 of about 932 (190)

Эндотелиопротекторное действие милдроната и его производных при моделировании L-NAME индуцированного дефицита оксида азота [PDF]

open access: yes, 2011
Результаты исследования 4 химических производных пропионата на лабораторных крысахyesБелгородский государственный ...
Даниленко, Л. М.   +4 more
core   +1 more source

Meldonium: drug which brought disrepute to sport [PDF]

open access: yes, 2017
World of sports have been rocked by doping scandals every now and then and World Anti-Doping Agency(WADA) has banned several offending drugs at different times to counter this menace.
Das, Smita   +2 more
core   +2 more sources

Rat spinal ganglia in assessment of protective action of antioxidants: A morphological study

open access: yesMedicina, 2017
Background and objective: Mercury pollution is one of the most pressing environmental problems. Therefore, the impact of mercury on human body, the nervous system in particular, remains topical.
Liudmyla M. Sokurenko   +4 more
doaj   +1 more source

Изучение противоишемической активности в ряду производных 3-(2, 2, 2-триметилгидразиний) пропионата при моделировании коронароокклюзионного инфаркта миокарда [PDF]

open access: yes, 2011
Результаты экспериментального исследования влияния 3-(2, 2, 2-триметилгидразиний) пропионата и его производных на площадь некротизированного миокарда левого желудочка при моделировании коронароокклюзионного инфаркта миокардаyesБелгородский ...
Даниленко, Л. М.   +4 more
core  

Mildronate treatment alters γ-butyrobetaine and l -carnitine concentrations in healthy volunteers [PDF]

open access: yes, 2011
Objectives In this study, we aimed to investigate the effects of long-term administration of the cardioprotective drug mildronate on the concentrations of l-carnitine and γ-butyrobetaine in healthy volunteers.
Bieber   +40 more
core   +1 more source

Mildronate improves cognition and reduces amyloid‐β pathology in transgenic Alzheimer's disease mice [PDF]

open access: yesJournal of Neuroscience Research, 2013
Mildronate, a carnitine congener drug, previously has been shown to provide neuroprotection in an azidothymidine‐induced mouse model of neurotoxicity and in a Parkinson's disease rat model. The aim of this study was to investigate the effects of mildronate treatment on cognition and pathology in Alzheimer's disease (AD) model mice (APPSweDI ...
Ulrika, Beitnere   +5 more
openaire   +2 more sources

Partial deficiency of HIF-1α stimulates pathological cardiac changes in streptozotocin-induced diabetic mice [PDF]

open access: yes, 2014
BACKGROUND: Diabetic cardiomyopathy is associated with a number of functional and structural pathological changes such as left ventricular dysfunction, cardiac remodeling, and apoptosis.
David Sedmera   +6 more
core   +1 more source

Влияние медикаментозной терапии на клиническое и психоэмоциональное состояние больных с хронической сердечной недостаточностью и сохраненной фракцией выброса [PDF]

open access: yes, 2018
На сегодняшний день отсутствуют результаты исследований, демонстрирующие снижение смертности на фоне лечения больных с хронической сердечной недостаточностью (ХСН) и сохраненной фракцией выброса, при этом данный синдром остается ведущей причиной ...
Вихрова, Т.А.   +3 more
core  

Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats [PDF]

open access: yes, 2009
Background and purpose: Mildronate [3-(2,2,2-trimethylhydrazinium) propionate] is an anti-ischaemic drug whose mechanism of action is based on its inhibition of L-carnitine biosynthesis and uptake.
Azuma   +28 more
core   +1 more source

COMPARATIVE EFFECTIVENESS OF CARDIOCYTE PROTECTORS IN COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION

open access: yesРоссийский кардиологический журнал, 2009
The study investigated the effects of cardiocyte protectors, mexicor and mildronate, in combination with ACE inhibitors, on blood levels of lipid peroxidation products, vascular endothelial function, circadian profile of blood pressure, and left ...
F. E. Khlebodarov   +2 more
doaj  

Home - About - Disclaimer - Privacy